Randomized controlled trials and comparative effectiveness research
- PMID: 23071239
- DOI: 10.1200/JCO.2012.42.2352
Randomized controlled trials and comparative effectiveness research
Abstract
Comparative effectiveness research (CER) has been promoted as a way to improve the translation gap between clinical research and everyday clinical practice as well as to deliver more cost-effective health care. CER will account for a significant portion of funding allocated by the US government for health care research. Oncology has a rich history of improving clinical outcomes and advancing research through randomized controlled trials (RCTs). In this article, we review the role of RCTs in achieving the goals of CER, with particular emphasis on the role of publicly funded clinical trials.
Similar articles
-
The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.Clin Trials. 2012 Aug;9(4):436-46. doi: 10.1177/1740774512450097. Epub 2012 Jul 2. Clin Trials. 2012. PMID: 22752634
-
Comparative effectiveness research: opportunities in surgical oncology.Semin Radiat Oncol. 2014 Jan;24(1):43-8. doi: 10.1016/j.semradonc.2013.09.003. Semin Radiat Oncol. 2014. PMID: 24314341 Review.
-
Methodology for comparative effectiveness research: potential and limitations.J Clin Oncol. 2012 Dec 1;30(34):4185-7. doi: 10.1200/JCO.2012.44.8233. Epub 2012 Oct 15. J Clin Oncol. 2012. PMID: 23071226 No abstract available.
-
An overview of methods for comparative effectiveness research.Semin Radiat Oncol. 2014 Jan;24(1):5-13. doi: 10.1016/j.semradonc.2013.09.002. Semin Radiat Oncol. 2014. PMID: 24314337 Review.
-
Perioperative comparative effectiveness research.Best Pract Res Clin Anaesthesiol. 2011 Dec;25(4):535-47. doi: 10.1016/j.bpa.2011.08.004. Best Pract Res Clin Anaesthesiol. 2011. PMID: 22099919 Review.
Cited by
-
The Aging, Community and Health Research Unit Community Partnership Program (ACHRU-CPP) for older adults with diabetes and multiple chronic conditions: study protocol for a randomized controlled trial.BMC Geriatr. 2022 Feb 4;22(1):99. doi: 10.1186/s12877-021-02651-7. BMC Geriatr. 2022. PMID: 35120457 Free PMC article.
-
Propensity score methods for comparative-effectiveness analysis: A case study of direct oral anticoagulants in the atrial fibrillation population.PLoS One. 2022 Jan 24;17(1):e0262293. doi: 10.1371/journal.pone.0262293. eCollection 2022. PLoS One. 2022. PMID: 35073380 Free PMC article.
-
Combining primary cohort data with external aggregate information without assuming comparability.Biometrics. 2021 Sep;77(3):1024-1036. doi: 10.1111/biom.13356. Epub 2020 Aug 25. Biometrics. 2021. PMID: 32827153 Free PMC article.
-
Efficacy of Neoadjuvant Chemotherapy with Epirubicin and Cyclophosphamide and Weekly Paclitaxel and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Carcinoma: A Real-World Study.Biomed Res Int. 2020 May 2;2020:3208391. doi: 10.1155/2020/3208391. eCollection 2020. Biomed Res Int. 2020. Retraction in: Biomed Res Int. 2024 Mar 20;2024:9785671. doi: 10.1155/2024/9785671. PMID: 32461977 Free PMC article. Retracted.
-
The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME).BMJ Open. 2019 Feb 21;9(2):e023568. doi: 10.1136/bmjopen-2018-023568. BMJ Open. 2019. PMID: 30796119 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
